Arbutus Biopharm

ABUS NASDAQ
2.000
-0.090
-4.31%
Closed 16:39 05/23 EDT
Open
2.090
Prev Close
2.090
High
2.145
Low
1.990
Volume
279.27K
Avg Vol (3M)
295.79K
52 Week High
12.60
52 Week Low
1.990
% Turnover
0.49%
Market Cap
113.70M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Arbutus Biopharm ABUS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company develops a portfolio of drug candidates with multiple mechanisms of action that results in a combination therapy to cure HBV. In addition to its HBV pipeline, the Company actively licenses its Lipid Nanoparticle (LNP) technology to its industry partners. This technology represents a delivery technology in RNA interference (RNAi) therapeutic development, which has enabled several clinical trials and has been administered to hundreds of human subjects.
MORE >

Recently

Name
Price
%Change